Here, we review the function of IKAROS in lymphocyte development and its association with a treatment-refractory disease phenotype in B-ALL with the goal of delineating potential therapeutic treatment strategies to address this high-risk leukemia. The gene discussed is IKZF1; the disease is leukemia.